An Interesting Imaging Presentation of a Common Benign Entity: Fibrocystic Changes in a Postmenopausal Patient.

benign breast condition breast pathology fibrocystic breast changes polycystic ovarian syndrome postmenopause

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Mar 2023
Historique:
accepted: 16 03 2023
medline: 19 4 2023
pubmed: 19 4 2023
entrez: 19 04 2023
Statut: epublish

Résumé

Fibrocystic changes (FCCs) are common, often benign, breast lesions characterized by adenosis, fibrosis, and cyst formation. These changes are believed to be associated with fluctuating hormone levels and are predominantly found in premenopausal women due to higher levels of estrogen. Certain conditions that cause hormonal imbalances, such as polycystic ovarian syndrome, have also been associated with an increased risk of FCCs. FCCs can occur in postmenopausal women on hormonal replacement therapy but are otherwise extremely rare. Although this condition is primarily considered benign, complex cysts presenting in a rare demographic warrant further evaluation beyond screening mammograms to exclude the possibility of malignancy. In this paper, we present the case of new FCCs in a postmenopausal woman and explore the radiology, histology, carcinogenic potential, treatment options, and potential contributing factors of the condition.

Identifiants

pubmed: 37073209
doi: 10.7759/cureus.36292
pmc: PMC10106097
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e36292

Informations de copyright

Copyright © 2023, Dang et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Obstet Gynecol Neonatal Nurs. 1990 Mar-Apr;19(2):116-21
pubmed: 2181087
Radiol Clin North Am. 2010 Sep;48(5):931-87
pubmed: 20868895
J Midlife Health. 2021 Jan-Mar;12(1):3-7
pubmed: 34188419
N Engl J Med. 1982 Oct 14;307(16):1010-4
pubmed: 7110289
Cancer Causes Control. 2016 Mar;27(3):403-14
pubmed: 26797454
J Clin Endocrinol Metab. 2011 Jun;96(6):1827-34
pubmed: 21450988
J Natl Cancer Inst. 2003 Feb 19;95(4):302-7
pubmed: 12591986
Am J Prev Med. 1987 Sep-Oct;3(5):282-6
pubmed: 2838061
Obstet Gynecol Sci. 2016 Sep;59(5):367-72
pubmed: 27668199
Arch Gynecol Obstet. 2009 Aug;280(2):249-53
pubmed: 19123007
Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2337-43
pubmed: 18725513
Am J Obstet Gynecol. 1986 Jan;154(1):161-79
pubmed: 3511705
Cancer Cell Int. 2022 Mar 19;22(1):125
pubmed: 35305643
Radiol Oncol. 2017 May 7;51(2):130-136
pubmed: 28740447
N Engl J Med. 2005 Jul 21;353(3):229-37
pubmed: 16034008
Acta Clin Croat. 2018 Dec;57(4):756-761
pubmed: 31168213
Arch Pathol Lab Med. 1998 Dec;122(12):1053-5
pubmed: 9870852
Radiology. 2019 Jul;292(1):77-83
pubmed: 31112087

Auteurs

Brittany Q Dang (BQ)

Radiology, University of Texas Medical Branch, Galveston, USA.

Brittany Miles (B)

Radiology, University of Texas Medical Branch, Galveston, USA.

Peter Young (P)

Radiology, University of Texas Medical Branch, Galveston, USA.

Jing He (J)

Pathology, University of Texas Medical Branch, Galveston, USA.

Quan D Nguyen (QD)

Radiology, Baylor College of Medicine, Houston, USA.

Classifications MeSH